Xcout Intel
Scout Bio, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Scout Bio, Inc. among biotechnology companies — ranked by similarity to what Scout Bio, Inc. actually does, not by market-cap band.
Subscribe to see Scout Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Scout Bio, Inc.
Scout Bio, Inc. is a veterinary biotechnology company specializing in animal health and advanced gene therapy treatments currently being evaluated in clinical trials.
Scout Bio, Inc. at a glance
Scout Bio, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $4.8M in October 2021. Xcout tracks 11 named people at Scout Bio, Inc., including Dr Sébastien Huron (DEPUTY CEO).
Scout Bio, Inc. leadership
- Dr Sébastien HuronDEPUTY CEO
- Christophe BailetEXECUTIVE VICE-PRESIDENT, CHIEF FINANCIAL OFFICER
- Dr Marc PrikazskyEXECUTIVE CHAIRMAN
- Jean-Marcel CietEXECUTIVE VICE PRESIDENT GLOBAL COMPANION ANIMALS
- David DerainEXECUTIVE VICE-PRESIDENT, HUMAN RESOURCES
- Dr Andras BolcskeiEXECUTIVE VICE-PRESIDENT, GLOBAL SALES OPERATIONS
5 more named people on record for Scout Bio, Inc., with roles, board committees and tenure — see the full roster →
Scout Bio, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.8M | — | |
| Series B | $33M | 12 named | |
| SEC Form D filing | $20M | — | |
| Series B | $20M | 11 named | |
| SEC Form D filing | $9.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Scout Bio, Inc. competitors
Ranked by semantic similarity — how close each company is to Scout Bio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Biotech
Loyal is a biotechnology company developing longevity medications designed to extend the healthspan and lifespan of dogs by targeting the underlying biological processes of aging. The company provides veterinary professionals with clinical resources, education, and trial opportunities while offering dog owners information on senior canine care and aging.
Similar biotechnology company
Curelab Veterinary Inc. is a biotechnology company headquartered in Boston, Massachusetts, devoted to developing innovative veterinary therapeutics and treatments to help pets combat cancer and live longer lives.
Similar biotechnology company
Skylark Bio is a biotechnology company developing precision-targeted, locally delivered gene therapies to treat genetic hearing loss and other single-gene disorders. The company's platform aims to restore natural biological processes and hearing function, addressing conditions that affect children and individuals with genetic communication impairments.
Similar biotechnology company
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Similar biotechnology company
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Similar biotechnology company
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Biotech
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Similar biotechnology company
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Similar biotechnology company
ELIAS Animal Health is a medical biotechnology company focused on advancing a pipeline of immunotherapies, including a unique treatment protocol and adoptive cell therapy that vaccinates companion animals using their own cancer cells.
Biotech
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Biotech
AAVantgarde Bio is an Italian biotechnology company developing adeno-associated virus (AAV) gene therapies for rare genetic diseases, including conditions caused by genes too large to fit into a single AAV vector. Its technology uses dual-AAV approaches to deliver larger therapeutic genes, serving patients with serious inherited disorders and the clinicians who treat them.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Scout Bio, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Scout Bio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →